170900 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Dong-A ST Co., Ltd. engages in the manufacture and sale of pharmaceutical products. Its products include medicines for gastric mucous membrane protection, antihistaminic agents, ischemic improvements, antithrombotic, functional digestion, hyperlipemia cure, growth hormone, anti-peptic ulcer cure, cerebral metabolic, high blood pressure, and others. The company was founded on March 1, 2013 and is headquartered in Seoul, South Korea.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
170900 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company